Welcome to Advanced Search

NCI-H1975 [H-1975, H1975]

Strain Name：NCI-H1975 [H-1975, H1975]
Strain State ： Validation of tumorigenic capacity completed |  Cat. NO.：NM-F07

NCI-H1975 (H-1975, H1975) is a cell line exhibiting epithelial morphology that was isolated in 1988 from the lungs of a nonsmoking female with non-small cell lung cancer.

HEPG2

Strain Name：HEPG2
Strain State ： Validation of tumorigenic capacity completed |  Cat. NO.：NM-G02

Hep G2 [HEPG2] is a cell line exhibiting epithelial-like morphology that was isolated from a hepatocellular carcinoma of a 15-year-old, White, male youth with liver cancer.

Combining genomic and network characteristics for extended capability in predicting synergistic drugs for cancer

Model Organisms：斑马鱼 Product & Service：- Research field：Drug screening and drug mechanism

Anti-Cancer Synergy MCF7 xenograft model

SH3RF3 promotes breast cancer stem-like properties via JNK activation and PTX3 upregulation

Model Organisms：Mouse Product & Service：M-NSG Research field：Breast cancer

DNA of neutrophil extracellular traps promotes cancer metastasis via CCDC25

Model Organisms：Mouse Product & Service：CCDC25 Research field：cancer metastasis

Transcriptional Regulation of the Warburg Effect in Cancer by SIX1.

Model Organisms：小鼠 Product & Service：SIX1 Research field：Cancer

Warburg效应

Targeting UBE2T Potentiates Gemcitabine Efficacy in Pancreatic Cancer by Regulating Pyrimidine Metabolism and...

Model Organisms：小鼠 Product & Service：KPC Research field：Pancreatic Cancer

Chromatin Remodeling Induced by ARID1A Loss in Lung Cancer Promotes Glycolysis and Confers JQ1 Vulnerability

Model Organisms：小鼠 Product & Service：- Research field：

Perivenous stellate cells are the main source of myofibroblasts and cancer‐associated‐fibroblasts formed after...

Model Organisms：Mouse Product & Service：Col1a1-e(Kozak-BFP-WPRE-pA) Research field：Liver tumor

A novel antibody targeting TIM-3 resulting in receptor internalization for cancer immunotherapy

Model Organisms：Mouse Product & Service：TIM-3 Research field：Cancer immunotherapy